Teva to buy Auspex for $101/share in cash
March 30, 2015 at 07:09 AM EDT
Teva said the deal would add a portfolio of drugs for the treatment of central nervous system disorders.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.